Position in ALEC
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$542,437
+$202,574 QoQ
Shares Held
252,297
+15.8% QoQ
Ownership
0.227%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 80%
Shared 0%
None 20%
Common Shares in ALEC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Bank of New York Mellon Corp holds $4,203,725,512 across 270 Biotechnology names. ALEC ranks #202 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,586,427 | $708,403,098 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
765,411 | $591,387,145 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,679,371 | $317,485,079 | |
| 4 | INSM |
INSMED Inc
|
1,262,749 | $206,484,708 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
491,200 | $162,523,337 | |
| 6 | INCY |
Incyte Corp
|
989,709 | $93,151,403 | |
| 7 | TECH |
BIO-TECHNE Corp
|
1,759,119 | $91,931,549 | |
| 8 | MRNA |
Moderna, Inc.
|
1,691,205 | $85,913,207 |
All Filings in ALEC
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $542,437 | 252,297 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $339,863 | 217,862 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $664,471 | 224,484 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $376,420 | 268,872 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $306,877 | 249,494 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $436,077 | 230,729 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $1,053,667 | 226,109 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $1,270,917 | 279,938 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $1,386,483 | 230,313 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $1,668,234 | 209,052 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $1,503,326 | 231,995 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $1,410,973 | 234,771 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $1,294,247 | 209,087 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $1,954,710 | 211,778 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,114,792 | 223,551 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,074,853 | 204,218 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $2,945,417 | 206,696 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $4,227,322 | 204,713 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $4,203,922 | 184,221 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $3,506,646 | 168,346 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $3,671,742 | 182,311 | Shares | Defined | 2021-05-13 | |
| 2020-09-30 | $7,285,878 | 691,588 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $23,968,478 | 980,707 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $7,892,125 | 327,067 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||